(Q28195766)

English

Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease

scientific article (publication date: May 2003)

In more languages

Statements

scholarly article

0 references

Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

tetrahydroisoquinolines

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714159

27 December 2023

Cardiology and cardiovascular medicine

1 reference

10.1016/S0002-9149(03)00161-9

https://api.crossref.org/works/10.1016/S0002-9149(03)00161-9

27 December 2023

author name string

Sanjay Rajagopalan

3

0 references

Stamatios Lerakis

4

0 references

Sampath Parthasarathy

6

0 references

Wright B. Lauten

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714159

27 December 2023

Qamar A. Khan

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714159

27 December 2023

Syed T. Rahman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714159

27 December 2023

Bobby V. Khan

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714159

27 December 2023

language of work or name

0 references

publication date

1 May 2003

0 references

full work available at URL

https://api.elsevier.com/content/article/PII:S0002914903001619?httpAccept=text/xml

1 reference

10.1016/S0002-9149(03)00161-9

https://api.crossref.org/works/10.1016/S0002-9149(03)00161-9

27 December 2023

https://api.elsevier.com/content/article/PII:S0002914903001619?httpAccept=text/plain

1 reference

10.1016/S0002-9149(03)00161-9

https://api.crossref.org/works/10.1016/S0002-9149(03)00161-9

27 December 2023

American Journal of Cardiology

0 references

91

0 references

1116-9

0 references

9

0 references

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Reversing endothelial dysfunction with ACE inhibitors. A new trend

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Maximally reducing cardiovascular risk in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900161-9

7 January 2021

Identifiers

10.1016/S0002-9149(03)00161-9

0 references

release_bkub5revtbavtf3rm4frijtux4

1 reference

https://api.fatcat.wiki/v0/release/bkub5revtbavtf3rm4frijtux4

24 November 2022

based on heuristic

mapped directly with Wikidata item

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28195766&oldid=2038467459"